
Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists.

PROPITEST 100 (USA WAREHOUSE)
DHB 100 (USA WAREHOUSE)
DIANABOL 50 (USA WAREHOUSE)
CJC1295 DAC IN KIT OF 10 VIALS (USA WAREHOUSE) 

